Neurofilament light levels predict clinical progression and death in multiple system atrophy

Disease-modifying treatments are currently being trialled in multiple system atrophy. Approaches based solely on clinical measures are challenged by heterogeneity of phenotype and pathogenic complexity. Neurofilament light chain protein has been explored as a reliable biomarker in several neurodegen...

Descripción completa

Detalles Bibliográficos
Autores principales: Chelban, Viorica, Nikram, Elham, Perez-Soriano, Alexandra, Wilke, Carlo, Foubert-Samier, Alexandra, Vijiaratnam, Nirosen, Guo, Tong, Jabbari, Edwin, Olufodun, Simisola, Gonzalez, Mariel, Senkevich, Konstantin, Laurens, Brice, Péran, Patrice, Rascol, Olivier, Le Traon, Anne Pavy, Todd, Emily G, Costantini, Alyssa A, Alikhwan, Sondos, Tariq, Ambreen, Ng, Bai Lin, Muñoz, Esteban, Painous, Celia, Compta, Yaroslau, Junque, Carme, Segura, Barbara, Zhelcheska, Kristina, Wellington, Henny, Schöls, Ludger, Jaunmuktane, Zane, Kobylecki, Christopher, Church, Alistair, Hu, Michele T M, Rowe, James B, Leigh, P Nigel, Massey, Luke, Burn, David J, Pavese, Nicola, Foltynie, Tom, Pchelina, Sofya, Wood, Nicholas, Heslegrave, Amanda J, Zetterberg, Henrik, Bocchetta, Martina, Rohrer, Jonathan D, Marti, Maria J, Synofzik, Matthis, Morris, Huw R, Meissner, Wassilios G, Houlden, Henry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762941/
https://www.ncbi.nlm.nih.gov/pubmed/35903017
http://dx.doi.org/10.1093/brain/awac253

Ejemplares similares

Ejemplares similares